SCHEMBL17732838

SCHEMBL17732838

C=Cc1ncnc2ccc(I)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.45
▸ EGFR P00533 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32
▸ GAK O14976 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15040807 0.79 HTT (0.56) KDM4EALDH1A1LMNAHPGDMTOR
SCHEMBL18630257 0.77 PARP1 (0.48) PARP1EGFRLMNAHTTCCNC
SCHEMBL10703592 0.73 SMN1; SMN2 (0.50) PARP1EGFRALDH1A1LMNAHTT
SCHEMBL17059455 0.73 PARP1 (0.46) PARP1KDM4EALDH1A1LMNAHPGD
SCHEMBL6978920 0.72 PARP1 (0.44) PARP1EGFRKDM4EALDH1A1LMNA
SCHEMBL28532923 0.72 PARP1 (0.44) PARP1EGFRLMNAHTTCCNC
SCHEMBL140574 0.72 PDE4A (0.53) PARP1EGFRKDM4EALDH1A1LMNA
SCHEMBL217203 0.72 PARP1 (0.44) PARP1EGFRLMNACCNCCDK8
SCHEMBL29390639 0.72 PDE4A (0.53) PARP1EGFRKDM4EALDH1A1LMNA
SCHEMBL5930896 0.72 MAP4K4 (0.56) MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2485731-B1 HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS MILLENNIUM PHARM INC (US) 2016-05-11 — — EP disclosed
Send feedback